About ClearFlow
ClearFlow is a company based in Irvine (United States) founded in 2007 by Edward Boyle. ClearFlow has raised $56.37 million across 16 funding rounds from investors including Aphelion Capital, California Technology Ventures and Research Corporation Technologies. ClearFlow offers products and services including PleuraFlow and ClearFix. ClearFlow operates in a competitive market with competitors including Rejoni, Cordis, Peters Surgical, Lotus Surgicals and Confluent Surgical, among others.
- Headquarter Irvine, United States
- Founders Edward Boyle
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$56.37 M (USD)
in 16 rounds
-
Latest Funding Round
$2.07 M (USD), Seed
Jul 24, 2025
-
Investors
Aphelion Capital
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ClearFlow
ClearFlow offers a comprehensive portfolio of products and services, including PleuraFlow and ClearFix.
Device for maintaining chest drain patency post-cardiac surgery.
System for stabilizing sternal fractures after surgical procedures.
People of ClearFlow
Unlock access to complete
Unlock access to complete
Funding Insights of ClearFlow
ClearFlow has successfully raised a total of $56.37M across 16 strategic funding rounds. The most recent funding activity was a Seed round of $2.07 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ClearFlow
ClearFlow has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Aphelion Capital, California Technology Ventures and Research Corporation Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech and life sciences focused VC firm investing in geographies such as the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Research Corporation Technologies is engaged in licensing biomedical technologies.
|
Locked | Locked | Locked |
Investor details for ClearFlow
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ClearFlow
Investment portfolio details for ClearFlow
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ClearFlow
Detailed financials for ClearFlow
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clearflow Comparisons
Peer comparison for ClearFlow
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ClearFlow
ClearFlow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rejoni, Cordis, Peters Surgical, Lotus Surgicals and Confluent Surgical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for women's health conditions are developed using innovative hydrogels.
|
|
| Locked | Locked | Locked |
Cardiovascular and endovascular devices are developed and marketed by Cordis.
|
|
| Locked | Locked | Locked |
Surgical disposables and medical supplies are developed and distributed globally.
|
|
| Locked | Locked | Locked |
Developer of a portfolio of surgical devices
|
|
| Locked | Locked | Locked |
Dural repair, surgical sealants, and adhesion barrier products are developed.
|
Detailed competitors of ClearFlow
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clearflow
Complete news archive for ClearFlow
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ClearFlow
ClearFlow was founded in 2007 and raised its 1st funding round 2 years after it was founded.
ClearFlow is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Hannah Beathard is the current CEO of ClearFlow.
ClearFlow is a funded company, having raised a total of $56.37M across 16 funding rounds to date.
ClearFlow was founded in 2007 in Irvine, United States, as a medical device company. Obstructed catheters are addressed through innovative technologies, with the lead product PleuraFlow ACT employing a magnetically driven loop to maintain fluid evacuation from the chest cavity and prevent Retained Blood syndrome after cardiothoracic surgery. Applications extend to urinary, gastrointestinal, and wound drainage segments.
ClearFlow's top competitors include Rejoni, Cordis and Lotus Surgicals.
ClearFlow offers PleuraFlow and ClearFix.
ClearFlow has 4 investors. Key investors include Aphelion Capital, California Technology Ventures, Research Corporation Technologies, and Oregon Venture Fund.